New therapeutic targets and strategies in lung cancer

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archivos de bronconeumología 2002-08, Vol.38 (8), p.386-391
1. Verfasser:	Sánchez De Cos Escuín, J
Format:	Artikel
Sprache:	spa
Schlagworte:	Alkyl and Aryl Transferases - antagonists & inhibitors Angiogenesis Inhibitors - therapeutic use Antineoplastic Agents - therapeutic use Benzamides Benzodiazepines - therapeutic use Clinical Trials as Topic Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Endothelial Growth Factors - antagonists & inhibitors Endothelial Growth Factors - immunology Enzyme Inhibitors - therapeutic use Epidermal Growth Factor - antagonists & inhibitors ErbB Receptors - antagonists & inhibitors Erlotinib Hydrochloride Farnesyltranstransferase Gefitinib Humans Imatinib Mesylate Imidazoles - therapeutic use Intercellular Signaling Peptides and Proteins - immunology Lung Neoplasms - drug therapy Lymphokines - antagonists & inhibitors Lymphokines - immunology Metalloendopeptidases - antagonists & inhibitors Multicenter Studies as Topic Piperazines Polyisoprenyl Phosphates - metabolism Protein-Tyrosine Kinases - antagonists & inhibitors Pyrimidines - therapeutic use Quinazolines - therapeutic use Quinolones - therapeutic use Randomized Controlled Trials as Topic Receptor Protein-Tyrosine Kinases - antagonists & inhibitors Sesquiterpenes Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0300-2896
DOI:	10.1016/S0300-2896(02)75244-7